Feed LCTX.TA
LC
Lineage Cell Therapeutics, Inc.
LCTX.TA · TLV
337.60 ILA +2.24% (+7.40 ILA)
1M -12.43%
Valuation
-
N/A P/E N/A
PEG N/A
EV/EBITDA N/A
Growth
14 /100
Declining Rev. growth 0.33%
Book val. growth 15.31%
EPS growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
-
N/A ROIC N/A
Asset turnover N/A
ROE N/A
Debt
-
N/A Debt/Equity N/A
Net debt/EBITDA N/A
Current ratio N/A
Stability
8 /100
Unstable Beta 1.55x
Profitable years 0
Rev. volatility 46.20%
Întreabă StockBot despre LCTX.TA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Brian Culley
Employees
75
Headquarters
Carlsbad
Evenimente viitoare
05 NOV.
Earnings
Upcoming earnings report